September 28, 2023
Attention: CGS J15 Local Coverage Determination (LCD) L36690/A56696
Skin Substitute Grafts/Cellular and/or Tissue-Based Products for the Treatment of Diabetic Foot Ulcers and Venous Leg Ulcers
L36690/A56696 Skin Substitute Grafts/Cellular and/or Tissue-Based Products for the Treatment of Diabetic Foot Ulcers and Venous Leg Ulcers will not become effective on 10/01/2023. This was to replace the existing policy (also L36690) which will remain in effect.
A new Proposed LCD will be published for comment and presented at an Open Meeting in the near future.